Apple (AAPL) vs Johnson & Johnson (JNJ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Johnson & Johnson (JNJ) has outperformed Apple (AAPL) over the past year, gaining 36.8% versus a gain of 31.3%. Over five years, AAPL leads with a +132.4% price change compared with +60.2% for JNJ. Apple is the larger company by market cap ($4.97 trillion vs $618.09 billion), about 8.0 times the size.
On valuation, Johnson & Johnson trades at a lower forward P/E (21.2x vs 35.5x for Apple). Johnson & Johnson offers the higher dividend yield (2.04% vs 0.31%). Johnson & Johnson converts more of its revenue into profit, with a net margin of 28.5% versus 26.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPL | JNJ |
|---|---|---|
| Share price | $340.42 | $256.48 |
| Market cap | $4.97T | $618.09B |
| 1-day change | +1.11% | -0.76% |
| YTD return | +23.84% | +24.89% |
| 1-year return | +31.27% | +36.83% |
| 5-year return | +132.44% | +60.23% |
| P/E ratio (TTM) | 39.04 | 29.72 |
| Forward P/E | 35.51 | 21.19 |
| EPS (TTM) | $8.72 | $8.63 |
| Dividend yield | 0.31% | 2.04% |
| Annual dividend | $1.05 | $5.24 |
| Revenue (latest FY) | $416.16B | $94.19B |
| Revenue growth (YoY) | +6.43% | +6.05% |
| Net income (latest FY) | $112.01B | $26.80B |
| Gross margin | 46.91% | 67.88% |
| Operating margin | 31.97% | — |
| Net margin | 26.92% | 28.46% |
| 52-week high | $345.34 | $281.07 |
| 52-week low | $243.42 | $184.66 |
| Distance from 52-week high | -1.42% | -8.75% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -3.62% | +9.03% |
| Average volume | 45.41M | 7.02M |
| Shares outstanding | 14.59B | 2.41B |
| Employees | 150,000 | 138,200 |
| Sector | Technology | Health Care |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Apple is about 8.0 times larger than Johnson & Johnson by market value ($4.97T vs $618.09B).
- Apple trades at a higher earnings multiple (39.0x vs 29.7x trailing P/E).
- Johnson & Johnson offers a meaningfully higher dividend yield (2.04% vs 0.31%).
- The two companies sit in different sectors: Apple in Technology and Johnson & Johnson in Health Care.
About Apple
AAPL stock →Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Technology · Computer Manufacturing · 150,000 employees
About Johnson & Johnson
JNJ stock →Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
Health Care · Biotechnology: Pharmaceutical Preparations · 138,200 employees
AAPL vs JNJ FAQ
Which is bigger, Apple or Johnson & Johnson?
Apple (AAPL) is larger, with a market capitalization of $4.97T compared with $618.09B for Johnson & Johnson (JNJ).
Which stock has performed better over the past year, AAPL or JNJ?
JNJ returned +36.83% over the past 12 months, compared with +31.27% for AAPL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, AAPL or JNJ?
JNJ has the lower trailing P/E at 29.7, versus 39.0 for AAPL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Apple or Johnson & Johnson?
Johnson & Johnson has the higher yield at 2.04%, compared with 0.31% for Apple.
Are Apple and Johnson & Johnson in the same industry?
No. Apple is in the Technology sector, while Johnson & Johnson is in Health Care.